Structural features of the interfaces in enzyme-inhibitor complexes.
about
Multi-spectroscopic and molecular modeling studies of interaction between two different angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate and human serum albumin.Screening from the world's largest TCM database against H1N1 virus.Structure and stability analysis of cytotoxic complex of camel α-lactalbumin and unsaturated fatty acids produced at high temperature.Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.New insight into the mechanism of mitochondrial cytochrome c functionProtein-protein interactions: principles, techniques, and their potential role in new drug development.A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin.Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.Molecular modeling of Mycobacterium tuberculosis dUTpase: docking and catalytic mechanism studies.Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.Biphasic association of T7 RNA polymerase and a nucleotide analogue, cibacron blue as a model to understand the role of initiating nucleotide in the mechanism of enzyme action.An insight into the ribonucleolytic and antiangiogenic activity of buffalo lactoferrin.Compounds of the 1,5-di(4-R-phenyl)- 3-selenopentanediones-1,5 series interaction with the basidiomycete Lentinula edodes lectins: computations and experiment.Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.
P2860
Q30395765-A16FA2B7-59AE-41D5-8BB7-4591E1EAF53AQ30399346-79F391DD-C193-4889-B71C-47666A099ED2Q30401575-22587ABA-F941-4048-885A-360D912B1925Q36117238-AFD1EBCD-964C-4B05-BCFC-025CE76C3C19Q36386388-D7A7C02C-E63A-4E89-B321-9C68585A16C9Q37862224-98070D00-257A-4A0D-9A4C-6338B06F623BQ39148033-8B0FD777-4F4B-4969-A26C-5609C77A5A10Q39482778-4602D9AE-8822-496D-AAE6-C5FCF6744042Q41932456-3D307D52-9B37-4350-AAE3-07F73E64F4BBQ43414532-0AA8DC13-E344-4E00-AA82-698446295526Q45330213-5E880B75-878B-4656-9332-91DB34072EA5Q50275626-109EFEDF-5AAD-4E99-AA96-9DC0FD794408Q51134890-92A8AEF4-E753-476B-99EF-919E826FC627Q51602625-7193B1FD-4C9E-4AE0-9028-50F2CBE574DBQ53250654-3E34BA9B-D7B5-4168-BE9B-12B0C293456A
P2860
Structural features of the interfaces in enzyme-inhibitor complexes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Structural features of the interfaces in enzyme-inhibitor complexes.
@en
Structural features of the interfaces in enzyme-inhibitor complexes.
@nl
type
label
Structural features of the interfaces in enzyme-inhibitor complexes.
@en
Structural features of the interfaces in enzyme-inhibitor complexes.
@nl
prefLabel
Structural features of the interfaces in enzyme-inhibitor complexes.
@en
Structural features of the interfaces in enzyme-inhibitor complexes.
@nl
P2860
P1476
Structural features of the interfaces in enzyme-inhibitor complexes.
@en
P2093
Nekrasov AN
Zinchenko AA
P2860
P356
10.1080/07391102.2010.10507345
P577
2010-08-01T00:00:00Z